Deutsche Bank analyst Pito Chickering raised the firm’s price target on Boston Scientific to $55 from $45 and keeps a Hold rating on the shares post the Q1 results. The company is "firing on all cylinders," the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BSX:
- Boston Scientific commentary lowers odds of ShockWave deal, says Evercore
- Boston Scientific price target raised to $58 from $53 at Canaccord
- Boston Scientific price target raised to $56 from $53 at Barclays
- Boston Scientific Gains on Q1 Beat
- Boston Scientific raises FY23 adjusted EPS view to $1.90-$1.96 from $1.86-$1.93